Pharma news
Americas
With growing legislation, research and demand for medical use, cannabis presents an economic opportunity for the Caribbean—but IP rights in the region have some way to go, write Keesha Fleming Lake of Keesha Fleming Lake, and Rachael Lodge Corrie of Foga Daley. 28 August 2025
Europe
A high number of filings from China has driven patent applications up by nearly a third at Ireland’s intellectual property office, which also reported a rise in SPC applications and strong activity in the medtech sector. 28 August 2025
Americas
In a New Jersey lawsuit, Henlius and Organon are accused of submitting an aBLA for a biosimilar that infringes two dozen patents. 19 August 2025
Americas
A pair of patents behind an infringement case that proved expensive for Amgen have been found “unenforceable due to inequitable conduct”. 15 August 2025
Americas
A patent fee structure being mooted in the US could hurt the innovation economy, especially in industries like biotech and pharma—and will face backlash from businesses, writes Paul Hunter of Foley. 12 August 2025
Americas
Payout and licensing deal grants US rights to COVID-19 and flu products | Agreement paves way for BioNTech’s $1.25 billion acquisition of CureVac. 8 August 2025
Europe
Captisol dispute intensifies as Italian court sides with Bexson | CyDex claims of trade secret misuse dismissed in early-stage ruling | Case relates to ongoing US dispute. 7 August 2025
Pharma
With AI accelerating drug development, pharma companies must rethink how they protect models, data, and innovation, say Camille Terfve and Sean Jauss of Mewburn Ellis. 6 August 2025
Europe
A much-anticipated referral could upend the EPO’s controversial description amendment rule—and reshape European patent practice, as the Enlarged Board of Appeal prepares to weigh in on G 1/25. 5 August 2025
Europe
UK Court of Appeal upholds key Moderna patent against Pfizer and BioNTech | Comirnaty vaccine ruled to infringe European mRNA technology patent. 4 August 2025